HMMS in Action: Transforming Hospital Medicines Management

National Push for Digital Medicines Control

Ireland's Health Service Executive (HSE) is deploying the Hospital Medicines Management System (HMMS) as a single, centrally hosted national platform to modernise pharmacy operations in acute and non-acute hospitals. This system handles stock control, dispensing, labelling, ward supply, procurement, and reporting, replacing fragmented local setups with a shared patient file and interoperability via standards like HL7 messaging and the Individual Health Identifier (IHI).

The project gained momentum from procurement starting around 2020-2021, with recent implementations accelerating in 2025: sites such as University Hospital Galway, the Rotunda Hospital, St. Vincent's University Hospital, and Children's Health Ireland at Crumlin have completed go-lives, marking a shift from paper-heavy processes to digital traceability. The 2025 HSE National Service Plan explicitly continued this rollout across acute hospitals and community pharmacy departments, aligning with broader e-health goals under the Digital for Care framework.

Hospital medicines management carries high stakes in Ireland. Medication-related harm remains a persistent issue globally and locally, with errors in dispensing, administration, or inventory leading to adverse events, extended stays, or readmissions in a system already grappling with waiting lists and capacity strains. Inefficient stock management contributes to waste, overstocking of expiring drugs, or shortages during demand spikes, while poor visibility inflates costs—pharmaceutical expenditure in public hospitals runs into hundreds of millions annually, exacerbated by high-cost biologics and new therapies.

The push for HMMS reflects wider digital transformation pressures. Ireland lags some European peers in electronic prescribing and closed-loop medication administration; HMMS supports future integration with national e-prescribing (NePS, targeted for 2027-2028) and the National Medicinal Product Catalogue. Yet the rollout is not seamless: early sites demonstrate gains in efficiency and safety, but scaling nationally risks temporary disruptions during transitions, staff training burdens, and integration challenges with existing patient administration systems or robotic dispensers.

Non-obvious tensions include the balance between centralised control for data insights and analytics—enabling better cost monitoring and procurement leverage—and the reality of diverse hospital needs across regions. Funding via EU recovery resources adds urgency to deliver value, while inaction perpetuates reliance on manual processes vulnerable to human error and cyber risks, as seen in broader HSE IT incidents.